Home » Stocks » Inogen

Inogen, Inc. (INGN)

Stock Price: $34.90 USD 0.66 (1.93%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $34.00 -0.90 (-2.58%) Aug 7, 4:15 PM

Stock Price Chart

Key Info

Market Cap 770.11M
Revenue (ttm) 330.86M
Net Income (ttm) 6.48M
Shares Out 22.07M
EPS (ttm) 0.29
PE Ratio 120.34
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $34.90
Previous Close $34.24
Change ($) 0.66
Change (%) 1.93%
Day's Open 34.16
Day's Range 33.93 - 35.34
Day's Volume 192,203
52-Week Range 28.57 - 76.89

More Stats

Market Cap 770.11M
Enterprise Value 561.99M
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 22.07M
Float 18.30M
EPS (basic) 0.3
EPS (diluted) 0.29
FCF / Share 1.33
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.83%
FCF Yield 3.80%
Payout Ratio n/a
Shares Short 2.60M
Short Ratio 10.54
Short % of Float 26.72%
Beta 0.70
PE Ratio 120.34
Forward PE n/a
P/FCF Ratio 26.32
PS Ratio 2.33
PB Ratio 2.15
Revenue 330.86M
Operating Income -1.74M
Net Income 6.48M
Free Cash Flow 29.26M
Net Cash 208.12M
Net Cash / Share 9.43
Gross Margin 51.94%
Operating Margin -0.53%
Profit Margin 2.00%
FCF Margin 8.84%
ROA -0.23%
ROE 1.89%
ROIC 6.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 0
Overweight 0
Hold 5
Underweight 0
Sell 1

Analyst Consensus: Hold

Price Target

$34.33*
(-1.63% downside)
Low
30.0
Current: $34.90
High
38.0
Target: 34.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue36235824920315911375.4448.5830.63
Revenue Growth1.07%43.57%22.98%27.56%41.29%49.17%55.31%58.57%-
Gross Profit17217912197.3176.2655.5238.9923.9514.70
Operating Income19.7937.8927.5922.8615.0510.514.460.83-1.72
Net Income20.9551.8521.0020.5211.596.8325.440.56-2.00
Shares Outstanding21.8221.2720.6820.0719.4016.180.280.260.25
Earnings Per Share0.942.300.960.970.560.300.68-19.97-20.15
EPS Growth-59.13%139.58%-1.03%73.21%86.67%-55.88%---
Operating Cash Flow40.5959.9860.4931.0338.1615.7013.474.001.86
Capital Expenditures-6.51-12.97-10.23-8.02-12.49-16.24-18.14-12.45-8.96
Free Cash Flow34.0847.0050.2723.0225.67-0.54-4.68-8.44-7.10
Cash & Equivalents20924017411482.9056.8413.5215.110.00
Total Debt6.72---0.320.6110.658.94-
Net Cash / Debt20224017411482.5856.222.876.180.00
Assets44737627521416114082.4047.59-
Liabilities10365.4748.0331.9627.3021.9426.1019.01-
Book Value345310227182134118-62.37-80.77-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Inogen, Inc.
Country United States
Employees 1,020
CEO Scott Wilkinson

Stock Information

Ticker Symbol INGN
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: INGN
IPO Date February 14, 2014

Description

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.